Parallel Advisors »

Cns Pharmaceuticals shares owned by Parallel Advisors

Quarter-by-quarter ownership of Cns Pharmaceuticals (CNSP) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Cns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cns Pharmaceuticals held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cns Pharmaceuticals by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 1 0.00
2024-06-30 $2 1 2.00

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Apple Stock (AAPL)
Corcept Therapeutics Stock (CORT)
Nvidia Corp Stock (NVDA)
Microsoft Stock (MSFT)
Ishares Core Msci Eafe Etf Etf (IEFA)
Amazon.com Stock (AMZN)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Vanguard Large Cap Etf (VV)
Cvb Finl Corp Stock (CVBF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Vanguard Total Stk Mkt Etf (VTI)
Costco Wholesale Corp Stock (COST)

View all positions for Parallel Advisors

Top funds holding Cns Pharmaceuticals

Geode Capital Management
Virtu Financial
Jane Street
Aspire Private Capital
Bank of America Corporation
Tower Research Capital
Wells Fargo & Company
Morgan Stanley
Global Retirement Partners
Northwestern Mutual Wealth Management Company
Plante Moran Financial Advisors
Parallel Advisors

View all funds holding Cns Pharmaceuticals